UPDATE : Friday, June 5, 2020
Antipyretic Fiblast makes 4th attempt to get insurance benefits
Fiblast, a cell therapy product to treat burn injuries, will make its fourt...
by Lee Hye-seon  |  2017-07-03 17:15
Regulators exclude Dong-A ST drug’s gastritis-preventing function from insurance benefits
Beginning this month, Dong-A ST will not be able to receive insurance benef...
by Lee Hye-seon  |  2017-07-03 16:10
‘Orphan’ drugs emerge as new targets of pharmaceuticals
Pharmaceutical companies have been increasingly developing drugs for rare d...
by Marian Chu  |  2017-07-03 16:01
Shire Korea improves its hemophilia B treatment
Shire Korea has improved the function of its Hemophilia B treatment, Rixubi...
by Constance Williams  |  2017-07-03 14:07
Health industry export exceeds $10 billion for 1st time last year
Korea’s export of medicines and medical equipment exceeded $10 billion for ...
by Kwak Sung-sun  |  2017-06-30 14:11
Hepatitis C treatment data presented at ‘Liver Week 2017’
Korea BMS Pharma (CEO: Park Hye-sun) presented their research of genotype 1...
by Constance Williams  |  2017-06-30 10:51
Celltrion applies for FDA approval of anticancer biosimilar
The U.S. Food and Drug Administration (FDA) has accepted Celltrion’s applic...
by Constance Williams  |  2017-06-29 18:03
Pfizer executive discusses social responsibility on insurance treatments
Michael Goettler, the global president of rare disease business at Pfizer, ...
by Constance Williams  |  2017-06-29 16:42
Handok aims to dominate patch market with new production plant
Handok Tuesday celebrated the completion of its state-of-the-art “plaster” ...
by Marian Chu  |  2017-06-28 15:36
Perfusate maker’s whim puts urologists on roller-coaster ride
The domestic urology clinics have fluctuated between hopes and fears recent...
by Song Soo-youn and Lee Hye-seon  |  2017-06-28 15:07
GSK picks cell therapy, new drugs as targets of innovation
GlaxoSmithKline (GSK) said Tuesday it would focus on developing cellular an...
by Constance Williams  |  2017-06-28 13:50
Il-yang exports anti-ulcer drug to Cambodia for 1st time
Il-yang Pharm (CEO: Kim Dong-yeon) has completed the first shipment of its ...
by Marian Chu  |  2017-06-28 10:50
Can Korean drugmakers develop dementia therapy?
As the Moon Jae-in administration speeds up the implementation of its polic...
by Lee Hye-seon  |  2017-06-28 09:44
Pharmaceutical industry most active in creating jobs
The pharmaceutical industry’s employment growth rate was far higher than ov...
by Lee Hye-seon  |  2017-06-27 18:10
Why doesn’t Samsung develop new drugs?
"We are interested in developing new drugs. And we will do so, by all means...
by Lee Hye-seon  |  2017-06-26 15:57
First patient resistant to Viread found in Korea
A Korean doctor has found patients who showed resistance to Viread (compoun...
by Park Gi-taek  |  2017-06-26 13:40
Pfizer vows patient access for new breast cancer drug
Pfizer Korea said Friday the company would do its utmost to ensure patient ...
by Constance Williams  |  2017-06-23 13:04
Roche, Celgene fight for No. 1 spot in oncology market
EvaluatePharma, which analyzes pharmaceuticals and biotech companies, said ...
by Marian Chu  |  2017-06-23 11:54
CSL Behring gets FDA approval for rare genetic disease drug
The U.S. Food and Drug Administration Thursday approved Haegarda, CSL Behri...
by Marian Chu  |  2017-06-23 11:44
Why Roche Korea can’t unveil research results of new lung cancer therapy?
Roche Korea is treading carefully in promoting Alecensa (compound: alectini...
by Nam Doo-hyun  |  2017-06-22 16:36
Back to Top